[Gastroenterology and hepatology in 2019]

Area of Science:

• Gastroenterology
• Hepatology
• Internal Medicine

Background:

• Significant advancements in gastroenterology and hepatology occurred in 2019.
• Clinical practice guidelines and treatment protocols underwent important updates.

Purpose of the Study:

• To review the most significant innovations and updates in gastroenterology and hepatology from 2019.
• To provide a concise overview of key findings and recommendations.

Main Methods:

• Literature review of major studies and clinical trials published in 2019.
• Synthesis of findings related to various gastrointestinal and liver conditions.

Main Results:

• Ursodeoxycholic acid's role in pregnancy cholestasis is debated.
• Aspirin shows potential in preventing fibrotic non-alcoholic fatty liver disease (NAFLD).
• Tenofovir is confirmed as the standard for treating hepatitis B virus (HBV) in pregnancy.
• Carvedilol's efficacy in portal hypertension is reaffirmed.
• Increased surveillance for intraductal papillary mucinous neoplasms (TIPMP) is recommended.
• Systematic colonoscopy post-acute diverticulitis is advised.
• Celiac disease surveillance protocols are updated.
• Tofacitinib is effective for ulcerative colitis, with precautions.
• Budesonide tablets are validated for eosinophilic esophagitis.

Conclusions:

• The year 2019 brought several critical updates impacting the management of diverse gastrointestinal and hepatological conditions.
• Clinicians should be aware of these advancements for optimal patient care.